XENE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.43%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,077,150.31

Xenon Pharmaceuticals Insider Trading History Chart

Xenon Pharmaceuticals Share Price & Price History

^$39.50

▼ -1.59 (-3.87%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

Fed launches fourth dollar overhaul

From Stansberry Research | Ad

You've likely heard a million different warnings about the changes taking place in America's financial system right now... How the White House plans to take the dollar fully digital???

Just click here now for the full story.

Xenon Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/7/2024	Robin Sherrington	EVP	Sell	7,137	$46.28	$330,300.36	8,398
3/7/2024	Steven Gannon	Director	Sell	13,000	$46.28	$601,640.00	2,000
12/13/2023	Gary Patou	Director	Sell	11,380	$39.29	$447,120.20	23,573
8/24/2023	Dawn Svoronos	Director	Sell	25,000	$38.70	$967,500.00	25,000
5/31/2023	Simon N. Pimstone	Director	Sell	62,526	$38.70	$2,419,756.20	6,000
5/24/2023	Ian Mortimer	CEO	Sell	31,655	$41.41	$1,310,833.55	24,213
3/24/2023	Christopher John Kenney	Insider	Sell	700	$35.01	$24,507.00
3/7/2023	Simon N. Pimstone	Director	Sell	19,232	$36.98	$711,199.36	34,002
11/25/2022	Gary Patou	Director	Sell	1,937	$34.79	$67,388.23	23,573
11/23/2022	Gary Patou	Director	Sell	2,057	$34.33	$70,616.81	23,573
8/15/2022	Simon N. Pimstone	Director	Sell	33,942	$37.76	$1,281,649.92	58,058
8/12/2022	James R. Empfield	EVP	Sell	57,743	$38.31	$2,212,134.33	10,000
8/12/2022	Simon N. Pimstone	Director	Sell	91,135	$38.28	$3,488,647.80	92,000
3/7/2022	James R. Empfield	EVP	Sell	32,853	$30.54	$1,003,330.62
3/7/2022	Simon N. Pimstone	Director	Sell	31,086	$30.50	$948,123.00
3/4/2022	Robin Sherrington	EVP	Sell	21,710	$30.50	$662,155.00
3/4/2022	Simon N. Pimstone	Director	Sell	9,325	$30.61	$285,438.25
1/21/2022	Christopher John Kenney	Insider	Buy	700	$28.81	$20,167.00
12/6/2021	Christopher Von Seggern	Insider	Buy	4,000	$24.40	$97,600.00
11/15/2021	Simon N. Pimstone	Director	Sell	17,557	$31.33	$550,060.81
5/28/2021	Robin Sherrington	EVP	Sell	6,067	$18.81	$114,120.27	29,141
5/27/2021	Frank A Holler	Director	Sell	11,064	$18.68	$206,675.52	125,127

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

SEC Filings (Institutional Ownership Changes) for Xenon Pharmaceuticals (NASDAQ:XENE)

95.45% of Xenon Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Xenon Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Assenagon Asset Management S.A.	186,606	$8.03M	0.0%	+87.1%	0.247%
4/11/2024	17 Capital Partners LLC	2,840	$0.12M	0.1%	N/A	0.004%
3/22/2024	PNC Financial Services Group Inc.	1,980	$91K	0.0%	N/A	0.003%
3/5/2024	Wellington Management Group LLP	4,162,654	$191.73M	0.0%	+140.9%	5.519%
3/1/2024	Goldman Sachs Group Inc.	376,302	$17.33M	0.0%	+47.4%	0.575%
2/26/2024	Perceptive Advisors LLC	1,100,748	$50.70M	1.1%	+78.3%	1.682%
2/20/2024	Quarry LP	1,000	$46K	0.0%	-77.8%	0.002%
2/15/2024	PFM Health Sciences LP	192,856	$8.88M	0.5%	+145.4%	0.295%
2/15/2024	Parkman Healthcare Partners LLC	294,788	$13.58M	1.9%	+36.1%	0.451%
2/15/2024	Great Point Partners LLC	600,000	$27.64M	4.7%	+20.0%	0.917%
2/15/2024	Granahan Investment Management LLC	302,581	$13.94M	0.5%	+28.1%	0.462%
2/15/2024	Boone Capital Management LLC	255,432	$11.77M	2.7%	N/A	0.390%
2/15/2024	Bridger Management LLC	146,800	$6.76M	2.6%	N/A	0.195%
2/15/2024	BVF Inc. IL	890,072	$41M	1.0%	-51.3%	1.360%
2/14/2024	First Light Asset Management LLC	1,645,490	$75.79M	6.1%	+173.3%	2.515%
2/14/2024	Commodore Capital LP	2,167,793	$99.85M	8.9%	+17.5%	3.313%
2/14/2024	Braidwell LP	1,647,311	$75.88M	2.8%	-21.7%	2.518%
2/14/2024	Avidity Partners Management LP	815,993	$37.59M	1.4%	+153.9%	1.247%
2/14/2024	Bellevue Group AG	22,000	$1.01M	0.0%	-7.9%	0.034%
2/14/2024	Avoro Capital Advisors LLC	5,666,666	$261.01M	3.6%	+15.6%	8.661%
2/14/2024	Lighthouse Investment Partners LLC	27,775	$1.28M	0.1%	N/A	0.042%
2/14/2024	Ghisallo Capital Management LLC	10,000	$0.46M	0.0%	N/A	0.015%
2/14/2024	Vestal Point Capital LP	175,000	$8.06M	0.9%	N/A	0.267%
2/13/2024	Tower Research Capital LLC TRC	1,014	$47K	0.0%	+414.7%	0.002%
2/13/2024	Capital World Investors	2,681,537	$123.51M	0.0%	+17.9%	4.098%
2/13/2024	Capital International Investors	2,455,683	$113.11M	0.0%	+0.4%	3.753%
2/13/2024	Affinity Asset Advisors LLC	460,000	$21.19M	3.9%	+53.1%	0.703%
2/13/2024	Campbell & CO Investment Adviser LLC	17,973	$0.83M	0.1%	N/A	0.027%
2/12/2024	Capstone Investment Advisors LLC	8,861	$0.41M	0.0%	N/A	0.014%
2/12/2024	Parallel Advisors LLC	1,125	$52K	0.0%	+51.2%	0.002%
2/9/2024	Westfield Capital Management Co. LP	237,495	$10.94M	0.1%	N/A	0.363%
2/9/2024	Aigen Investment Management LP	8,043	$0.37M	0.1%	N/A	0.012%
2/9/2024	Franklin Resources Inc.	293,825	$13.53M	0.0%	+70.2%	0.449%
2/9/2024	Assetmark Inc.	9,938	$0.46M	0.0%	+39.9%	0.015%
2/8/2024	Fiera Capital Corp	553,030	$25.47M	0.1%	-1.3%	0.845%
2/8/2024	Nicholas Investment Partners LP	87,752	$4.04M	0.5%	-89.7%	0.134%
2/8/2024	First Turn Management LLC	680,389	$31.34M	4.5%	N/A	1.040%
2/7/2024	Jump Financial LLC	24,000	$1.11M	0.0%	N/A	0.037%
2/7/2024	Teacher Retirement System of Texas	13,988	$0.64M	0.0%	-3.0%	0.021%
2/7/2024	TimesSquare Capital Management LLC	793,954	$36.57M	0.5%	+34.4%	1.213%
2/6/2024	Natixis Advisors L.P.	21,293	$0.98M	0.0%	-3.3%	0.033%
2/6/2024	Swiss National Bank	123,800	$5.70M	0.0%	+10.8%	0.189%
2/5/2024	Russell Investments Group Ltd.	174,286	$8.03M	0.0%	+2.9%	0.266%
2/2/2024	State of New Jersey Common Pension Fund D	71,013	$3.27M	0.0%	+10.2%	0.109%
2/1/2024	New York State Common Retirement Fund	190,312	$8.77M	0.0%	+3.1%	0.291%
2/1/2024	Jennison Associates LLC	566,396	$26.09M	0.0%	+164.9%	0.866%
1/31/2024	abrdn plc	32,036	$1.48M	0.0%	N/A	0.049%
1/31/2024	Federated Hermes Inc.	346,596	$15.96M	0.0%	N/A	0.530%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	15,584	$0.72M	0.0%	+34.1%	0.024%
1/24/2024	DekaBank Deutsche Girozentrale	39,000	$1.80M	0.0%	+95.0%	0.060%
1/24/2024	Arizona State Retirement System	17,552	$0.81M	0.0%	+21.2%	0.027%
1/24/2024	China Universal Asset Management Co. Ltd.	8,546	$0.39M	0.1%	+417.6%	0.013%
1/17/2024	Assenagon Asset Management S.A.	99,731	$4.59M	0.0%	-32.5%	0.152%
1/12/2024	SG Americas Securities LLC	18,606	$0.86M	0.0%	-67.2%	0.028%
1/4/2024	DNB Asset Management AS	126,375	$5.82M	0.0%	+3.8%	0.193%
12/6/2023	Citigroup Inc.	2,866	$98K	0.0%	-31.0%	0.004%
12/1/2023	Wellington Management Group LLP	1,728,108	$59.03M	0.0%	+64.4%	2.641%
11/22/2023	Polar Capital Holdings Plc	3,003,747	$102.61M	0.8%	-0.6%	4.591%
11/21/2023	Walleye Capital LLC	126,028	$4.31M	0.0%	+40.5%	0.193%
11/17/2023	TimesSquare Capital Management LLC	590,575	$20.17M	0.3%	+38.3%	0.903%
11/16/2023	TLS Advisors LLC	32,956	$1.13M	4.5%	-2.4%	0.050%
11/15/2023	Redmile Group LLC	419,568	$14.33M	0.7%	-62.6%	0.641%
11/15/2023	Adage Capital Partners GP L.L.C.	550,000	$18.79M	0.0%	-17.9%	0.841%
11/15/2023	Alps Advisors Inc.	47,349	$1.62M	0.0%	+1.3%	0.072%
11/15/2023	Advisors Asset Management Inc.	10,188	$0.35M	0.0%	+25.9%	0.016%
11/15/2023	Affinity Asset Advisors LLC	300,438	$10.26M	2.9%	+397.6%	0.459%
11/14/2023	Braidwell LP	2,103,396	$71.85M	2.2%	+15.0%	3.215%
11/14/2023	Schonfeld Strategic Advisors LLC	198,984	$6.80M	0.1%	+10.5%	0.304%
11/14/2023	Avidity Partners Management LP	321,400	$10.98M	0.4%	-33.2%	0.491%
11/14/2023	Qube Research & Technologies Ltd	54,285	$1.85M	0.0%	+81.1%	0.083%
11/14/2023	Nan Fung Group Holdings Ltd	106,680	$3.64M	3.0%	-6.7%	0.163%
11/13/2023	Algert Global LLC	128,487	$4.39M	0.2%	-11.3%	0.196%
11/13/2023	Rathbones Group PLC	23,666	$0.81M	0.0%	N/A	0.036%
11/13/2023	Silverarc Capital Management LLC	53,996	$1.85M	0.6%	-45.9%	0.083%
11/13/2023	Invesco Ltd.	716,303	$24.47M	0.0%	+2.3%	1.095%
11/13/2023	FMR LLC	4,252,866	$145.28M	0.0%	-18.0%	6.500%
11/13/2023	Lord Abbett & CO. LLC	1,149,168	$39.26M	0.1%	-41.3%	1.756%
11/9/2023	Loomis Sayles & Co. L P	730,716	$24.96M	0.0%	-3.0%	1.139%
11/9/2023	Fiera Capital Corp	560,546	$19.15M	0.1%	+2.0%	0.874%
11/8/2023	Swiss National Bank	111,700	$3.82M	0.0%	+1.7%	0.174%
11/8/2023	Moody Aldrich Partners LLC	9,123	$0.31M	0.1%	N/A	0.014%
11/7/2023	Barclays PLC	9,521	$0.32M	0.0%	+3.7%	0.015%
11/7/2023	Arizona State Retirement System	14,478	$0.50M	0.0%	+2.2%	0.023%
11/6/2023	Assenagon Asset Management S.A.	147,693	$5.05M	0.0%	N/A	0.230%
11/1/2023	Orion Portfolio Solutions LLC	15,402	$0.53M	0.0%	-2.6%	0.024%
10/31/2023	Teacher Retirement System of Texas	14,418	$0.49M	0.0%	+5.5%	0.022%
10/31/2023	Jennison Associates LLC	213,823	$7.30M	0.0%	+13.5%	0.333%
10/31/2023	China Universal Asset Management Co. Ltd.	1,651	$56K	0.0%	+98.2%	0.003%
10/27/2023	Assetmark Inc.	7,103	$0.24M	0.0%	+21.5%	0.011%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	11,623	$0.40M	0.0%	+26.4%	0.018%
10/24/2023	Bank of New York Mellon Corp	167,349	$5.72M	0.0%	-21.0%	0.261%
10/18/2023	Exchange Traded Concepts LLC	3,967	$0.14M	0.0%	+22.2%	0.006%
10/13/2023	SG Americas Securities LLC	56,752	$1.94M	0.0%	+44.5%	0.088%
10/13/2023	DnB Asset Management AS	121,770	$4.16M	0.0%	+8.1%	0.190%
10/12/2023	Legato Capital Management LLC	11,682	$0.40M	0.1%	-5.1%	0.018%
9/21/2023	Barclays PLC	9,179	$0.35M	0.0%	+9,079.0%	0.014%
8/24/2023	Perceptive Advisors LLC	1,223,377	$47.10M	1.4%	-33.2%	1.907%
8/21/2023	Affinity Asset Advisors LLC	60,376	$2.32M	0.8%	-32.9%	0.094%
8/15/2023	Silverarc Capital Management LLC	99,756	$3.84M	1.2%	+3.2%	0.156%
8/15/2023	Braidwell LP	1,828,353	$70.39M	2.3%	-14.4%	2.850%

Data available starting January 2016

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, a Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epileptic encephalopathy; and XEN1101, a Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.

Today's Range

Now: $39.50

$39.24

$41.16

50 Day Range

MA: $44.29

$39.50

$49.63

52 Week Range

Now: $39.50

$27.99

$50.99

Volume

325,554 shs

Average Volume

400,904 shs

Market Capitalization

$2.98 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15

Who are the company insiders with the largest holdings of Xenon Pharmaceuticals?: Xenon Pharmaceuticals' top insider investors include:
Simon N Pimstone (Director)
Dawn Svoronos (Director)
Ian Mortimer (CEO)
Gary Patou (Director)
James R Empfield (EVP)
Sherrington Robin (EVP)
Steven Gannon (Director)
Christopher John Kenney (Insider)
Learn More about top insider investors at Xenon Pharmaceuticals.
Who are the major institutional investors of Xenon Pharmaceuticals?: Xenon Pharmaceuticals' top institutional shareholders include:
Assenagon Asset Management S.A. — 0.25%
17 Capital Partners LLC — 0.00%
Learn More about top institutional investors of Xenon Pharmaceuticals stock.
Which major investors are buying Xenon Pharmaceuticals stock?: During the previous quarter, XENE stock was bought by institutional investors including:
Assenagon Asset Management S.A.
17 Capital Partners LLC